<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:DOC-EE26JAVQ</identifier><date>2022</date><creator>Berlec, Karla</creator><creator>Hribernik, Nežka</creator><relation>documents/doc/E/URN_NBN_SI_doc-EE26JAVQ_001.pdf</relation><relation>documents/doc/E/URN_NBN_SI_doc-EE26JAVQ_001.txt</relation><format format_type="type">article</format><format format_type="extent">Str. 113-115</format><identifier identifier_type="COBISSID_HOST">102350083</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-EE26JAVQ</identifier><language>slv</language><publisher publisher_location="Ljubljana">Katedra za onkologijo</publisher><publisher publisher_location="Ljubljana">Onkološki inštitut</publisher><publisher publisher_location="Ljubljana">Sekcija za internistično onkologijo</publisher><source>Melanom in nemelanomski kožni raki</source><rights>InC</rights><subject language_type_id="slv">kemoterapija</subject><subject language_type_id="slv">melanom</subject><subject language_type_id="slv">rak kože</subject><title>Clinical case of a patient with BRAF V600 mutant borderline resectable cutaneous melanoma and CLL</title><title>Elektronski vir</title><title>Klinični primer bolnika z BRAF V600 mutiranim, mejno resektabilnim kožnim melanomom in KLL</title></Record>